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Purpose: To characterize some preformulation properties of aqueous stem bark extract of Bridelia 
ferruginea Benth (Euphorbiaceae) (BF).                
Methods: The stem bark was extracted by maceration in hot distilled water. Two batches of granules 
containing the extract were prepared by wet granulation using maize starch, polyvinylpyrrolidone (PVP), 
Avicel® PH-101, magnesium stearate, acacia and lactose as excipients. Some physicochemical and 
micromeritic properties of the powdered extract and granules were determined following standard 
procedures.                                       
Results: The pH of the aqueous BF extract was 5.4 ± 0.1 while the moisture content of the dry extract 
was 12.0 %. Total ash value of the extract was 7.91 ± 0.03. Particle size increased after granulation 
from 228 to 531 µm in the order: granules 1 > granules 2 > powder. The bulk and tapped densities 
decreased significantly (p < 0.05) from 0.40 ± 0.04 to 0.77 ± 0.09 and 0.49 ± 0.05 to 0.85 ± 0.09 g/ml, 
respectively in the order: granules 2 < granules 1 < powder. Similarly, the angle of repose increased 
after granulation from 24.0 ± 0.5 to 25.4 ± 0.9 o in the order: granules 2 < granules 1 < powder (p < 
0.05). The flow rate and compressibility of the granules (2.45 ± 0.08 g/min and 0.17, respectively) 
improved significantly (p < 0.05) over those of the powdered BF extract (2.34 ± 0.05 g/min and 0.26, 
respectively). 
Conclusion: The results of this preformulation study indicates that the powdered extract of Bridelia 
ferruginea possesses properties that make it suitable for its formulation into standard solid dosage 
forms. 
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INTRODUCTION 
 
The term, herbal medicines, has been 
defined as medicinal products whose active 
ingredients are derived from aerial or 
underground parts of plants or other plant 
material or the combination of them, whether 
in the crude state or as a plant preparation [1-
3]. Plant material includes such substances 
as juices, gums, and oils. Herbal medicines 
may contain plant materials other than the 
active ingredients and may even contain 
other non-plant organic or inorganic active 
ingredients [1-3].  
 
Medicinal plants have played a key role in 
world health. They are distributed worldwide, 
but are most abundant in tropical countries. It 
has been estimated that about 25% of all 
modern medicines are directly or indirectly 
derived from plants [4]. Herbal drugs range 
from parts of plant, of which leaves, bark, 
roots, flowers and seeds are the most 
common, to isolated and purified active 
constituents. For use as medicines, they are 
usually eaten, swallowed, drunk, inhaled, or 
applied to the skin [5]. The plant materials are 
usually boiled in water to make decoctions 
[6].  
 
Phytotherapeutic agents or phytomedicines 
are standardized herbal preparations that 
contain, as active ingredients, complex 
mixtures of plant materials in the crude or 
processed state. Phytopharmaceuticals are 
always mixtures of many constituents and are 
therefore very variable and difficult to 
characterize. Standardization of the 
preparation of herbal medicines still poses 
great challenges today. Therefore, critical 
steps have to be taken for their proper 
identification, screening and standardization 
to ensure quality [7].  
 
Bridelia ferruginea Benth (Family: 
Euphorbiaceae) (BF) is a widely employed 
ethnomedicinal plant in several parts of Africa 
for the treatment of various ailments. It is 
usually used in the form of decoctions and 
extracts of parts of the plant and is about the 
most studied of the species Bridelia [8]. In 
Nigeria, it is commonly found in the 
Savannah and other more humid regions of 
Africa. The aqueous stem bark extract has 
been reported to demonstrate anti-
inflammatory, antipyretic and analgesic 
activities in vivo and in vitro [9] as well as 
significant antiplasmodial activity against 
Plasmodium berghei berghei in mice [10].  
 
Therefore, the objective of this study was to 
characterize the preformulation properties of 
Bridelia ferruginea stem bark extract in order 
to determine its suitability for formulation into 






Stem bark, leaves and fruits of BF, distilled 
water, and acacia gum (BDH, England) were 
used in the study, All other reagents were of 
analytical grade and used without further 
purification.  
 
Collection and identification of plant 
material 
 
The stem of the plant, BF, with its leaves and 
fruits, was collected fresh from Odenigbo, 
Nkalagu-Obukpa, Nsukka, Enugu State, 
Nigeria on May 24, 2010 and identified by 
Jamilat Ibrahim of the Department of 
Medicinal Plant Research & Traditional 
Medicine, National Institute for 
Pharmaceutical Research and Development 
(NIPRD), Abuja, Nigeria, and a voucher 
specimen (no. NIPRD/H/6414) kept for future 
reference at the NIPRD Herbarium.  
 
Preparation of crude extract 
 
The stem bark was extracted by maceration 
in hot distilled water as previously reported 
[10]. The bark was cleaned and scales 
removed. The clean bark was then cut into 
pieces, air-dried at room temperature for 7 
days and ground to powder using mortar and 
pestle. The powder was soaked in boiled 
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distilled water overnight and filtered. The 
filtrate was heated over a hot water bath to 
recover the dry extract which was pulverized 
and kept in an air-tight container pending 
further tests. 
 
Determination of organoleptic properties  
 
The colour and taste of the extract were 
assessed in line with the hedonic scale  
 
Determination of pH 
 
A 1 % w/v solution of BF extract in distilled 
water was prepared, filtered and the pH read 
on a pH meter (Accumet Research, model 
AR10, Fisher Scientific, Singapore), and the 
mean of triplicate readings taken. 
 
Moisture content determination 
 
Moisture content of the aqueous BF extract 
was determined by slight modification of the 
requirement in the British Pharmacopoeia 
(BP) for loss on drying of extracts [11]. A 
clean dry Petri dish was weighed and 1.0 g of 
the extract, accurately weighed with an 
analytical balance (AB54, Mettler Toledo, 
Switzerland), was placed on it. The Petri dish 
was then placed in a hot air oven (N30C, 
Genlab, England) set at 60 oC and the extract 
dried to constant weight (approx. 3 h). It was 
cooled over silica gel in a desiccator and re-
weighed. The per cent loss in weight was 
taken as moisture content. Triplicate 
measurements were made and mean 
recorded. 
 
Ash value determination 
 
The ash value of the extract was determined 
following method 1 of BP 2004 [11]. A silica 
crucible was dried in an oven for 10 min and 
weighed on an analytical balance (AB54, 
Mettler Toledo, Switzerland). A 2.0 g quantity 
of the powdered extract was weighed and 
spread in the crucible with a clean, dry 
spatula. The crucible and its content were 
then placed in an oven (Nabertherm, Karl 
Kolb Scientific Technical Supplies, D 6072, 
Dreleich, West Germany), heated to 450 oC, 
gradually cooled and then re-weighed 
immediately. Ash value was calculated as in 
Eq 1. Triplicate determinations were made 
and the mean taken. 
Ash value (%) = {(W2 – W1)/M}  ……… (1)  
 
where W1 = weight of the crucible, W2 = final 
weight of the crucible + ash, and M = initial 
weight of sample.  
 
Preparation and evaluation of granules 
 
Two batches of granules of the powdered 
extract were prepared by wet granulation. 
Using a 3% acacia mucilage, the mixture of 
the ingredients was wetted and the wet mass 
passed through a standard granulating sieve 
with the aid of a spatula. The granules were 
then dried in an oven at 60 oC for 1 h. Batch 
1 contained (as per hypothetical compressing 
weight of tablet) the extract (100 mg), maize 
starch (30 mg) as disintegrant and 3 % 
acacia mucilage (9 mg dry weight) as binder. 
Batch 2 was similar to Batch 1 in composition 
and quantities except that Avicel® PH-101 
and polyvinylpyrrolidone were used as 
disintegrant and binder, respectively. 
Magnesium stearate (lubricant) and D-lactose 
monohydrate, (bulking agent) were added to 
the granules for both batches prior to 
compression into tablets. The disintegrants 
were incorporated in the formulations 80 % 




The following micromeritic properties were 
assessed (in triplicate) for the powdered 
extract and granules.  
 
Bulk density (DB) 
 
A mass of the sample was screened through 
sieve of aperture size 850 µm, 16.37 g of 
which was poured at an angle of about 45o 
into a clean, dry, graduated 50 mL measuring 
cylinder. The volume occupied was noted 
and the mean DB calculated from Eq 2 [12]. 
DB = M/VB   ………………………. (2) 
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where M = weight of the sample and VB = 
mean bulk volume of the sample.  
 
Tapped density (DT) 
 
A 16.37 g quantity of the screened sample 
was poured at an angle of about 45o into a 
clean dry 50 mL measuring cylinder, placed 
on a Stampfvolumeter (JEL STAV, 2003 
model) and tapped until no further change in 
volume occurred. The constant volume was 
noted. Tapped density (DT) was calculated 
from Eq 3 [12]. 
DT    = M/VT   …………………….. (3) 
where M = weight of the sample and VT = 
tapped volume of the sample.  
 
Hausner ratio (HR) and Compressibility 
index (CI)  
 
The Hausner ratio (HR) and Compressibility 
index (CI) of the samples were derived from 
Eqs 4 and 5, respectively. 
HR = DT/DB    ………………… (4) 




A weighed amount of the sample was poured 
at an angle of about 45o into a clean dry 
graduated measuring cylinder and the initial 
volume (V0) noted. The cylinder was 
positioned on a tapping machine 
(Stampfvolumeter, JEL STAV 2003 model) 
and tapped intermittently, noting the tapped 
volume (V) after a specific number of taps 
(N). Tapping was continued until no further 
change in volume of the sample occurred. 
The degree of volume reduction during 
tapping (C) and the ratio of number of taps 
(N) to this degree were calculated from Eqs 6 
- 8 [13]. 
C = (V0 – V)/V0    …………….. (6) 
R = N/C      …………….. (7) 
N/C = N/a + 1/ab   …………….. (8) 
where R = ratio of number of taps to the 
degree of volume reduction, and a and b are 
constants; a describes the degree of volume 
reduction at the limit of tapping and is 
referred to as compressibility as it reflects the 
compactibility of the material; b relates to the 
cohesion and shear strength of the material.  
 
Eq 8, referred to as Kawakita equation, is 
applied in tapping experiments to assess the 
cohesiveness and compactibility of powdered 
materials, and hence their flow properties. 
 
 A plot of N/C against number of taps, N, 
gives a graph of slope equal to 1/a and 
intercept equal to 1/ab from which numerical 
values for the constants a and b can be 
obtained. While a gives an indication of the 
maximum of volume reduction available, 
characteristic for the powder and also known 
as compressibility, b describes an inclination 
towards volume reduction [13]. 
 
True density (Dt) 
 
The fluid displacement method was used for 
the determination of the true density of the 
powdered extract. A density bottle was 
washed, dried thoroughly in an oven and 
weighed. The bottle was then filled with 
xylene as the displacement fluid and 
weighed. Some of the xylene was removed 
from the bottle, and approximately 1.0 g 
quantity of the powdered extract, accurately 
weighed, and transferred into the bottle with 
sample and then weighed. Triplicate 
measurements were made and mean Dt 
computed from Eq 9. 
Dt = w/{(a + w) – b} x SG   ……… (9) 
where w = weight of the powdered extract 
(1.0 g); a = weight of density bottle + xylene; 
b = weight of density bottle + xylene + 
powdered extract; and SG = specific gravity 
of the displacement fluid, xylene (0.863). 
 
Flow rate and Angle of repose 
  
The fixed-height cone method [14] was used. 
A glass funnel was fixed at a 10 cm height 
over a flat horizontal surface. The exit/orifice 
of the funnel was temporarily blocked with a 
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flat ruler. A clean white paper was spread 
beneath the funnel on the horizontal surface 
for collection of the powder. A 16.35 g 
quantity of the sample was then weighed and 
poured into the funnel. The exit of the funnel 
was then sharply unblocked and the time 
(seconds) taken for the sample to completely 
flow out onto the horizontal surface was 
measured with a stop clock. The height and 
radius of the cone formed were measured 
with a ruler. Flow rate and angle of repose of 
the sample were calculated as in Eqs 10 and 
11: 
Flow rate = M/t    ……………….. (10) 
Angle of repose = tan A = h/r  …..…(11) 
where M = mass (g) of the sample, t = time 
(seconds) taken for the sample to completely 
flow out of the funnel, A = angle (o) formed by 
the sample cone, and h = height (cm) of the 
sample cone formed after flowing from the 
funnel. 
 
Particle size analysis  
 
A sieve-shaker assembly was used for this 
determination. A set of testing sieves 
(Standard Testing Sieves, ASTM E-11 
Specification, VWR Scientific, West Chester, 
USA) of sizes 150, 250, 500, 600, 710, 850 
µm and 1.00 mm were arranged in 
descending order on the shaker (Retsch 
2002, Germany). A 15.0 g quantity of the 
sample was poured on the top sieve (1.00 
mm) and a plate placed at the bottom. The 
shaker was run for 20 min at an amplitude of 
1.5 mm/g. At the end of the run, the amount 
of material retained on each sieve was 
weighed. The average particle size was 
computed as in Eq 12 [15]: 
Mean diameter = [∑ (% retained) x (mean 




The results were analyzed for statistical 
significance by Student’s t-test at 95 % 






The extract was brown in colour but had 




Table 1 shows a summary of the micromeritic 
properties and other physicochemical 
parameters of the preparations. The values 
generally indicate good flow properties for the 
powdered extract and granules. Significant 
variation in particle size distribution was 
observed with a preponderance (38.5 %) of 
fines over other sizes. Angle of repose, bulk 
and tapped densities decreased in the rank 
order: powder > Batch 1 > Batch 2. 
Expectedly, flow rate increased following 
granulation. The moisture content obtained 
(12.0 %) was high when compared to the 
normal limit of not more than 10.0 % as 
specified in the European Pharmacopoeia 
[16]. The ash value obtained (7.91 ± 0.03 %) 
was within pharmacopoeial limits of not more 
than 14.0 % [16].  Bulk density of the powder 
(0.77 ± 0.09 g/ml) was significantly higher 
than that obtained for granules of Batch 1 
(0.60 ± 0.08 g/ml) and this was in turn higher 
than that of Batch 2 (0.40 ± 0.04 g/ml) (Table 
1). Compressibility index increased 
significantly after granulation in the rank 
order: Batch 1 > Batch 2. The pH of the 
aqueous solution of the extract was slightly 
acidic. The Kawakita plots were linear with 




The bland taste of the extract is a good 
attribute as a formulator will not be bordered 
about taste masking. Also, cases of non-
compliance due to taste would be minimal. 
The pH of the extract is slightly acidic. 
According to the pH-partition hypothesis, 
weakly acidic drugs, which exist 
predominantly in the unionized form at gastric 
pH, are well absorbed from the stomach [17]. 
Although the chemistry of the extract is yet to  
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Table 1: Physicochemical characteristics of Bridelia ferruginea extract 
 
Granules  Parameter Powder 
Batch 1 Batch 2 
Colour Darkbrown - - 
Odour Nil - - 
Taste Nil - - 
pH 5.4±0.1 - - 
Moisture  
content (%) 
12.0±0.0 - - 
Ash value (%) 7.91±0.03 - - 
Bulk density 
(DB, g/ml) 
0.77±0.09 0.60±0.08 0.40±0.04 
Tapped density 
(DT, g/ml) 
0.85±0.09 0.75±0.01 0.49±0.05 
Hausner ratio  
(HR) 
1.20 1.25 1.21 
Compressibility  
index (CI, %) 
10.6 20.2 17.1 
True density  
(Dt, g/ml) 
1.39 - - 
Flow rate (g/s) 2.34 ± 0.05 2.45±0.08 2.45±0.08 
Angle of  
repose (0) 











0.996 0.955 0.985 
Mean particle diameter (µm) 228 531 458 
 
 
Fig 1: Kawakita plots for Bridelia ferruginea extract (Note: ◊ = powder; □ = Batch 1; ∆ = Batch 2) 
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be elucidated, it is probable that it is likely to 
be well absorbed from oral dosage forms in 
the stomach due to the weakly acidic nature. 
 
When a plant material is subjected to heat 
both water and volatile matter evaporate. The 
test for loss on drying therefore actually 
determines both water and volatile matter 
content. Excess of water content in herbal 
medicines promotes microbial growth, insect 
infestation, and deterioration by hydrolysis. It 
is, therefore, important to establish or set 
limits for water content for every plant 
material used in preparing phytomedicines, 
especially materials that will absorb moisture 
easily or deteriorate quickly in the presence 
of water. The desiccation method of 
determining water content is especially useful 
for materials that melt to a sticky mass at 
elevated temperatures while the azeotropic 
method gives a direct measurement of the 
water content of the material being examined 
[7]. The moisture content was rather high 
when compared to official requirement for 
herbal drug preparations of ≤ 10 % after 
drying for 2 h, unless otherwise justified [16].  
Total ash value indicates the total amount of 
material remaining from the plant extract after 
the carbon content have been burnt away by 
ignition [7]. This includes both ‘physiological 
ash’, which is derived from the plant tissue 
itself, and ‘non-physiological ash’, which is 
residue of extraneous matter (e.g., soil) 
adhering to the plant surface. Ash value is a 
criterion for judging the identity and purity of 
crude drugs. This parameter is very useful in 
evaluating the purity of powdered herbal and 
conventional drugs such as determination of 
adulteration with other plant parts or 
extraneous matter. The result obtained 
implies that the extract evaluated showed a 
high degree of purity, and was relatively low 
in inherent inorganic salts, such as calcium 
oxalate, and inorganic matter from external 
sources [16].                                                                                                                        
 
The micromeritic properties (bulk and tapped 
densities, HR, CI, flow rate, angle of repose 
and average particle size) obtained for the 
powdered extract generally indicate good 
flow properties. Angle of repose is 
characteristic of the internal friction or 
cohesion of the particles. It is high if cohesive 
and other forces are high and vice versa. 
Generally, if the angle exceeds 50o, the 
powder will not flow satisfactorily while 
materials having values near the minimum, 
circa 25o, flow easily and well [14]. From the 
results, it can be inferred that both the 
powder and the granule formulations would 
flow well into the die of the tablet press. 
 
It had been reported that HR values less than 
1.25 indicate good flow, while values greater 
than 1.25 indicate poor flow. HR values 
between 1.25 and 1.5 require addition of a 
glidant to improve flow [17]. The granules 
exhibited satisfactory flow properties. Powder 
as well as granule flow had been described 
as excellent for values of CI within 5 – 15 %, 
good for 12 -16 % and fair to passable for 18 
– 21 %, while between 23 – 35 % are said to 
be poor, 33 - 38 % are very poor and values 
> 40 % are extremely poor [17]. CI was 
excellent for the powdered BF extract, good 
for the Batch 2 granules and fair to passable 
for Batch 1 granules. HR and CI are useful 
indices for assessing drug powder and 
granule flow properties. An increase in 
particle size or a more uniform shape leads to 
a smaller angle of repose and smaller CI, and 
this is supported by the data obtained in the 
present study. However, CI is a one-point 
determination and therefore may not always 
reflect the ease or speed with which the 
powder or granules consolidates. Some 
materials may have high CI (indicating poor 
flow) yet may consolidate rapidly in the 
tableting machine die [17].  
 
The inverse relationship of the slope of the 
Kawakita plot implies that the higher the 
slope, the less the value of a, and the better 
the compressibility of the granules or powder. 
As the tapping was increased, the ratio of the 
number of taps to the degree of volume 
reduction also increased gradually. But the 
slope of the linear plot is in the rank order: 
powder < Batch 1 < Batch 2. In the Kawakita 
plot, a describes the degree of volume 
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reduction at the limit of tapping [13].  Hence, 
the high value of a for the powder correlates 
with its tendency to form very poor or no 
compacts. Similarly, the values of b obtained 
were in the rank order: powdered extract <  
Batch 1 <  Batch 2, indicating that the 
powdered particles of the extract were very 
cohesive, and hence had a greater tendency 
to form compacts than Batches 1 and 2 
granules. Batch 2 granules were the least 
cohesive, meaning that interparticulate forces 
favouring compression were least, and 
therefore, would most probably result in the 
production of friable tablets. The R2 values 
obtained from the plot show good linearity 
which was close to unity, indicating reliability 




This study demonstrates the feasibility of 
developing standard solid dosage forms, 
such as tablets and capsules, of the aqueous 
stem bark extract of B. ferruginea Benth for 
oral use. Their excellent micromeritic 
properties also indicate that the powdered 
extract can be packaged in sachets. Further 
research is, however, required to establish 
these possibilities and ascertain the stability 
and release properties of the dosage forms of 
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